Infanrix/Hib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Infanrix/Hib, covering 2009-08-26 to 2017-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine [Phase 3]